Summer Road LLC 的 Form 4 申報
Ocular Therapeutix, Inc（OCUL），2022/9/29 申報
- 申報編號
- 0001567619-22-017965
- 申報時間
- 2022/9/29
- 交易日
- 2022/9/27-9/29
- 申報延遲
- 2 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
這份申報列了 3 筆非衍生性交易。公開市場買進合計 $68.9 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Summer Road LLCCIK 0001604873 | 持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F4
Represents the weighted average set forth in this line item. On September 27, 2022, the Reporting Person acquired 130,000 shares of Common Stock at a weighted average price of $4.6794 (ranging from a low of $4.20 and a high of $5.31). Upon request by the SEC staff, the issuer or a security holder of the issuer, the Reporting Person will provide full information regarding the number of shares of Common Stock purchased or sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
Represents the weighted average set forth in this line item. On September 28, 2022, the Reporting Person acquired 1,200 shares of Common Stock at a weighted average price of $4.10 (all shares were purchased at a price of $4.10 and therefore no range has been provided).
表 I 有 1 筆交易的價格引用這則附註。
- F6
Represents the weighted average set forth in this line item. On September 29, 2022, the Reporting Person acquired 18,800 shares of Common Stock at a weighted average price of $4.0419 (ranging from a low of $4.00 and a high of $4.10). Upon request by the SEC staff, the issuer or a security holder of the issuer, the Reporting Person will provide full information regarding the number of shares of Common Stock purchased or sold at each separate price.
表 I 有 1 筆交易的價格引用這則附註。